Literature DB >> 21894615

The Cuban Public Registry of Clinical Trials: primary registry of World Health Organization.

Gladys Jiménez1, María Amparo Pascual, Martha Fors, José Cobas, Ania Torres, Yamilé Cachimaille, Julián Rodríguez, Isabel López.   

Abstract

Despite the importance of randomized trials for well-informed decisions in health care, a large proportion of the results of these trials are not published, especially when they are negative. Publication bias has a negative impact in the treatment of patients, due to the distorted impression it leads to for new therapies. Clinical Trial Registries help to overcome this by providing transparency in the process of conducting research. The World Health Organization takes the position that the registration of interventional trials is a scientific, ethical and moral responsibility. Taking account of this global movement, the National Coordinating Centre of Clinical Trials and the Cuban Health Network, designed and implemented the Cuban Public Registry of Clinical Trials. The Registry was established in June 2007 and is intended for public service in Cuban territory, although it is open to registrants and patients outside Cuba. The Registry staff developed a strategy to become a Primary Registry of the World Health Organization, and this was achieved in February 2011.
© 2011 Blackwell Publishing Asia Pty Ltd and Chinese Cochrane Center, West China Hospital of Sichuan University.

Entities:  

Mesh:

Year:  2011        PMID: 21894615     DOI: 10.1111/j.1756-5391.2011.01140.x

Source DB:  PubMed          Journal:  J Evid Based Med        ISSN: 1756-5391


  2 in total

Review 1.  Current status and future perspectives of immunotherapy in Latin America and Cuba.

Authors:  Alexander Diaz Rodriguez; Alexis Labrada Rosado; Raúl Lázaro Castro Almarales; Mirta Álvarez Castelló
Journal:  World Allergy Organ J       Date:  2014-11-12       Impact factor: 4.084

2.  Subcutaneous allergen immunotherapy for asthma: A randomized, double-blind, placebo-controlled study with a standardized Blomia tropicalis vaccine.

Authors:  Raúl Lázaro Castro-Almarales; Mercedes Ronquillo-Díaz; Mirta Álvarez-Castelló; José Rodríguez-Canosa; Mayda González-León; Irene Enríquez-Domínguez; Bárbara Ivonne Navarro-Viltre; Maytee Mateo-Morejón; Yunia Oliva-Díaz; Wendy Ramírez-González; Linda Cox; Alexis Labrada-Rosado
Journal:  World Allergy Organ J       Date:  2020-04-10       Impact factor: 4.084

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.